| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.0008 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |